Eduardo Tolosa

TL;DR: Clinical diagnostic criteria for probable and possible PD‐D are proposed, characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent.

TL;DR: Mutations in LRRK2 are a clinically relevant cause of PD that merit testing in patients with hereditary PD and in subgroups of patients with PD, but this knowledge should be applied with caution in the diagnosis and counselling of patients.

TL;DR: Clinical CBD phenotypes and features were combined to create 2 sets of criteria: more specific clinical research criteria for probable CBD and broader criteria for possible CBD that are more inclusive but have a higher chance to detect other tau-based pathologies.

TL;DR: The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment.

TL;DR: The neuropathology of Parkinsonian disorders clinical rating scale for tremor rating scales in Parkinson's disease tremors, differential diagnosis and pharmacology different clinical presentations of myoclonous tics dystomic syndromes and the pathophysiology of drug-induced movement disorders drug- induced dyskinesias akathisia and the restless legs syndrome ataxia.